Showing results (211-220 of 232) with videos related to
Sort By:
Pageof 24
Journal of Thrombosis and Haemostasis : JTH|December 9, 2017
Pharmacokinetics, clot strength and safety of a new fibrinogen concentrate: randomized comparison with active control in congenital fibrinogen deficiencyC Ross, S Rangarajan, M Karimi, et al.Journal of Thrombosis and Haemostasis : JTH|June 16, 2015
Plasma ADAMTS-13 levels and the risk of myocardial infarction: an individual patient data meta-analysisA Maino, B Siegerink, L A Lotta, et al.Bone Marrow Transplantation|June 18, 1999
Concurrent Pneumocystis carinii and cytomegalovirus pneumonia after autologous peripheral blood stem cell transplantationW M Chuu, J P Catlett, D J Perry, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 26, 2012
Genetics of haemostasisA C Goodeve, D J Perry, T Cumming, et al.Cancer|June 15, 1991
Chemotherapy with 5-fluorouracil (5-FU) and cisplatin or 5-FU, cisplatin, and vinblastine for advanced non-small cell lung cancer. A randomized phase II study of the cancer and leukemia group BF Richards, D J Perry, M Goutsou, et al.British Journal of Haematology|May 1, 1994
Prevalence of antithrombin deficiency in the healthy populationR C Tait, I D Walker, D J Perry, et al.Orphanet Journal of Rare Diseases|June 23, 2022
Lombardy diagnostic and therapeutic network of thrombotic microangiopathyI Mancini, P Agosti, M Boscarino, et al.Scientific Reports|November 6, 2022
Reduced circulating FABP2 in patients with moderate to severe COVID-19 may indicate enterocyte functional change rather than cell deathG Assante, A Tourna, R Carpani, et al.American Journal of Hematology|January 1, 1987
Bone marrow transplantation in a patient with myelodysplasia associated with diffuse eosinophilic fasciitisM S Tallman, R W McGuffin, C S Higano, et al.Cancer Treatment Reports|January 1, 1983
Phase II trial of mitoguazone in patients with advanced squamous cell carcinoma of the head and neckD J Perry, S M Crain, M D Weltz, et al.Pageof 24